CCL2 and COVID-19: Finally, these results are in line with clinical studies conducted among individuals with major depressive disorder, showing that several antidepressants, including fluoxetine, significantly decrease peripheral levels of IL-6, TNF-α, IL-10, and CCL-2 [53], which have been shown to increase in severe COVID-19 patients [54].